ESTERN Medical CRO Life Sciences Newsroom & Scientific Insights

Advancing Clinical Innovation Through Knowledge, Science, and Global Collaboration

Welcome to the official ESTERN Medical CRO Life Sciences Newsroom Press Releases & Scientific Articles Publications Blog—your source for company news, scientific publications, industry perspectives, clinical development and regulatory strategy insights shaping the global healthcare and Life Sciences landscape.

Designed for Life Sciences sponsors, biotechs, pharmaceutical companies, medical device innovators, investors, researchers, and strategic partners, this platform delivers timely, evidence-based content across Clinical Development Research, Regulatory Affairs, Commercialization, Market Access, and Go-To-Market strategy throughout the US, North America, and Latin America emerging markets.

  • To learn more about ESTERN Medical CRO Life Sciences, our global capabilities, and our expertise across Clinical Research, Regulatory Affairs, and Go-To-Market (GTM) strategies, please visit:

    www.esternmedical.com

Scientific Clinical innovation alone is not enough. Success requires strategic planning, regulatory expertise, operational excellence, and flawless execution.

ESTERN Medical partners with healthcare innovators to accelerate Clinical Development, strengthen Regulatory Strategy, and support successful commercialization across the Americas.

🚀 Your Innovation. Our Execution. Faster Together Across the Americas.

🧬 Clinical Research Development
đź“‹ Global Regulatory Strategy
🌎 Expansion Across the Americas
⚡ Commercial Readiness & GTM Execution

Because every day saved in clinical development brings innovation closer to the patients healthcare who need it most globally.

"We are the CRO of the Americas"

Contact Us

Innovating Life Sciences R&D healthcare, bridging continents, transforming patients lives globally.

Join us in advancing global healthcare today!

Welcome to the ESTERN Medical Newsroom

ESTERN Medical & Intrials Explore Strategic Collaboration

Boston, MA | May 28, 2026 — ESTERN Medical CRO Life Sciences met with the senior leadership team of Intrials Clinical Research during the 2026 ASGCT Annual Meeting in Boston, Massachusetts.

Representing ESTERN Medical was Dr. Jorge Estrella, MD, President & Chief Medical Officer, who met with Sergio Braga Filho, President & CEO of Intrials Clinical Research, together with Strategic Advisor Hugo Cabrera.

The discussion focused on potential collaborations in Clinical Research, Regulatory Strategy, Go-To-Market (GTM) initiatives, and healthcare market opportunities across the Biotechnology, Pharmaceutical, and Medical Device sectors throughout the United States, North America, and Latin America (LATAM).

As innovation continues to accelerate across the Life Sciences industry, partnerships such as these create opportunities to expand access to novel therapies, strengthen clinical development capabilities, and accelerate commercialization strategies.

Dr. Jorge Estrella commented: “The future of Life Sciences innovation depends on strong international collaborations that combine clinical development expertise, regulatory insight, and commercialization excellence.”

ESTERN Medical appreciates the opportunity to exchange perspectives and looks forward to continued discussions that may create value for sponsors, healthcare providers, and patients across international markets.

ESTERN Medical Joins THEORA AI Meeting at Harvard University

Cambridge, MA | April 2, 2026 — ESTERN Medical Life Sciences was invited to participate in a strategic meeting at Harvard University in Cambridge, Massachusetts, with Larissa Tyagi, Co-Founder & CEO, and Dr. William Shen, Co-Founder of THEORA AI.

The discussion brought together Dr. Jorge Estrella, President & Chief Medical Officer of ESTERN Medical Life Sciences, and THEORA AI leadership to explore the continued development of AI LOUIZA, an analyst-grade artificial intelligence platform designed to support biopharmaceutical development and strategic decision-making.

The meeting focused on how LOUIZA is being developed to synthesize fragmented global clinical, scientific, regulatory, and competitive intelligence data to support more informed decision-making across the product development lifecycle.

Key areas of discussion included competitive intelligence across evolving therapeutic landscapes, clinical development planning informed by historical and real-world precedent, and more rigorous evaluation of emerging biopharmaceutical research and development assets.

This invitation highlights ESTERN Medical Life Sciences’ ongoing contribution of clinical development, regulatory, and strategic expertise to innovative AI-driven platforms that have the potential to transform drug development, accelerate innovation, and support the future of global healthcare.

ESTERN Medical: Canada’s Role in Global Life Sciences Growth

Cambridge, MA | Jan. 28, 2026 🇨🇦 Life Sciences Without Borders: Why Canada Is Fast Becoming a Strategic Extension of U.S. Clinical R&D.

This past week, ESTERN Medical Life Sciences had the privilege of participating in “Think CANADA: The Life Science Innovation Partner,” hosted by the Consulate General of Canada in Boston on January 28, 2026, at the CIC in Cambridge, Massachusetts.

Under the leadership of Hon. Bernadette Jordan, Consul General of Canada in Boston, the event brought together policymakers, trade leaders, and Life Sciences executives to address a central 2026 question: how to accelerate clinical development, reduce risk, and scale global programs without compromising quality or compliance.

Canada continues to emerge as a strategic extension of the U.S. Life Sciences ecosystem, offering streamlined regulatory pathways, strong R&D incentives, high-performing clinical sites, diverse patient populations, and a collaborative innovation environment with competitive operational efficiencies.

For Biotech, Pharma, MedTech, and Digital Health organizations, cross-border clinical strategies are increasingly becoming a competitive advantage rather than an option.

At ESTERN Medical, Canada is viewed as a natural complement to U.S. and LATAM clinical development, enabling faster study execution, improved resilience, and more efficient end-to-end R&D and Go-To-Market execution.

The future of clinical research belongs to organizations that think globally and execute with precision.

Connect with ESTERN Medical Life Sciences to explore tailored solutions for your clinical research and regulatory development needs.

Join us on the journey to better healthcare!

ESTERN Medical Making Medicine Work

The Future of Life Sciences: Faster, Smarter, Borderless

Across continents, innovation is accelerating—but speed alone is not enough. From Boston’s biotech hub, ESTERN Medical Life Sciences connects North American innovation with Latin American opportunity to create a truly integrated clinical ecosystem across the Americas. We bridge science and execution, transforming complexity into clarity and ideas into action. In a world where healthcare is global and time is critical, we help biotech, pharma, and medtech innovators accelerate clinical development, navigate regulatory pathways, and scale across borders with precision. From discovery to delivery, from innovation to impact, ESTERN Medical Life Sciences is driving clinical research, regulatory strategy, and go-to-market execution across the Americas—because the future of healthcare moves fast, and it moves together.

Innovating healthcare, connecting continents, transforming lives every day.

Together, let’s advance the future of healthcare and improve lives through innovation, science, and collaboration.

Our Latest Scientific Article Publication - July 1st, 2026

Can AI Help Rebuild Healthcare After a Disaster? Lessons from Venezuela’s 2026 Earthquake Crisis and the Emerging Role of CROs

· Author: Dr. Jorge Estrella, MD, President & Chief Medical Officer, ESTERN Medical CRO Life Sciences.

As the healthcare community continues to respond to the devastating earthquakes that struck Venezuela on June 24, 2026, ESTERN Medical CRO Life Sciences extends its support to the patients, families, healthcare professionals, researchers, emergency responders, and humanitarian organizations working tirelessly throughout the recovery effort.

As a Clinical Research Organization (CRO) serving both the United States and Latin America, we recognize that healthcare resilience is built through collaboration, innovation, and a shared commitment to improving lives. While the immediate focus remains on saving lives and restoring access to medical care, this disaster also highlights the importance of long-term healthcare preparedness, public health coordination, emerging technologies, and global partnerships.

In this special edition, we examine the healthcare impact of the earthquakes in Venezuela, the international response, the role of artificial intelligence in healthcare in disaster recovery, and how Clinical Research Organizations can help strengthen healthcare systems during times of crisis.

Read the Full Article:

https://www.linkedin.com/pulse/can-ai-help-rebuild-healthcare-after-disaster-lessons-from-38txe

Our Clinical R&D Sponsors & Partnerships

Frequently Asked Questions (FAQ)

Our mission is to advance global life sciences, clinical trials research, and healthcare innovation by transforming scientific discoveries into accessible, life-changing therapies and solutions that improve the lives of patients worldwide.

Our U.S. North American headquarters is located in the Boston–Cambridge region of Massachusetts, New England, globally recognized as the Life Sciences and Biotechnology Capital of the World. Complementing our US-North American presence, ESTERN Medical operates through strategically located LATAM and South American subsidiaries in Mexico, Colombia, Chile, Argentina, and Brazil, providing seamless support across more than 22 countries throughout the Americas.

We empower Biotech, Pharmaceutical, and Medical Device companies to achieve successful Go-to-Market outcomes through integrated regulatory strategy, product registration and approval support, market access planning, commercialization guidance, and regional expansion initiatives tailored to the regulatory, healthcare, and business environments of each target market.

Contact Us Let’s Build Your Next Clinical R&D Success Together

Tel: +1 (617) 395-0204

Our Mailing Address: 955 Massachusetts Ave No. 203, Cambridge, MA 02139, USA